Desvenlafaxine Succinate Patent Expiration
Desvenlafaxine Succinate is Used for treating depression, including maintenance treatment of major depressive disorder. It was first introduced by Pf Prism Cv
Desvenlafaxine Succinate Patents
Given below is the list of patents protecting Desvenlafaxine Succinate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Pristiq | US8269040 | Derivatives of venlafaxine and methods of preparing and using the same | Jul 05, 2027 | Pf Prism Cv |
| Pristiq | US6673838 | Succinate salt of O-desmethyl-venlafaxine |
Mar 01, 2022
(Expired) | Pf Prism Cv |
| Pristiq | US6673838 | Succinate salt of O-desmethyl-venlafaxine |
Feb 11, 2022
(Expired) | Pf Prism Cv |
Desvenlafaxine Succinate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List